Go to deals
Software & Technology

Dye & Durham has completed an IPO onto TSX along with a primary and secondary placing

July 2020 — Dye & Durham Corporation has raised funds through an IPO and a primary and secondary placing.

Dye & Durham is a leading provider of software and technology solutions designed to boost efficiency and increase productivity for legal and business professionals. The Dye & Durham platform connects the largest global network of professionals with public records to support business transactions and regulatory compliance.

Our role in the transaction

Oaklins Cavendish’s sister firm finnCap, based in the UK, acted as the placing agent for Dye & Durham in this transaction.

Talk to the deal team

Peter Gray

Partner
London, United Kingdom
Oaklins Cavendish

Related deals

F.EE has been acquired by One Equity Partners
Private Equity | Software & Technology

F.EE has been acquired by One Equity Partners

F.EE GmbH, one of Germany’s leading providers of innovative solutions in mechanical engineering, automation hardware, cabinet control, software and robot programming, has been acquired by One Equity Partners. This transaction will strengthen the private equity firm’s operations in the industrial automation space. The sellers have reinvested and will remain involved in the business for the coming years.

Learn more
SRT Marine has completed a placing and subscription
Consulting & Business Services | Software & Technology

SRT Marine has completed a placing and subscription

SRT Marine Systems plc has announced an equity raise of at least US$22 million at US$1.10 per share representing a 5.75% discount, through a US$19.4 million accelerated bookbuild placing and a US$2 million subscription by Ocean Infinity, alongside a separate retail offer of up to US$1.3 million.

Learn more
IXICO has completed a fundraising
Healthcare Communications & Technology | Software & Technology

IXICO has completed a fundraising

IXICO plc, a specialist in AI-driven neuroimaging analytics, has completed a US$13.5 million gross capital raise. The funds will be used to support the company’s tech bio strategy, which will see IXICO partner its platform to maximize its potential.

Learn more